pillbase.ru

Tyruko

Active substance: natalizumab

natalizumab

Centralised EU authorisationActive

Marketing holder: Sandoz GmbH

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 2
  • TYRUKO
    INJECTION · NATALIZUMAB 300 mg/15mL
    61314-543
    Sandoz Inc
  • TYSABRI
    INJECTION · NATALIZUMAB 300 mg/15mL
    64406-008
    Biogen Inc.
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a12090-7ef9-79bf-afbd-e3a97b071efe,01a12096-8726-704f-8bed-57167353f376;count=2 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/005752
Registration status
Active
ATC code
L04AG03
Sources
  • product · EMA · EMEA/H/C/005752 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/005752 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/005752 · Verified 2026-10-09